http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014136999-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K2208-12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K8-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E21B43-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K8-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K8-607 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E21B21-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K8-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K8-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E21B21-062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K8-035 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K8-035 |
| filingDate | 2013-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2014136999-A |
| titleOfInvention | Clay Swelling Inhibitor, Compositions Including The Indicated Inhibitor, And Methods Using The Indicated Inhibitor |
| abstract | 1. The use of 2-methylpentane-1,5-diamine (MPMD) or the organic or inorganic salt of MPMD as an inhibitor of clay swelling in an aqueous medium. The use according to claim 1, wherein MPMD and / or its organic or inorganic salts correspond to at least 10% by weight relative to the total amount of clay swelling inhibitor in an aqueous medium. The use according to claim 1 or 2, wherein the organic MPMD salt is the MPMD carboxylic acid salt. The use of claim 3, wherein the organic MPMD salt is a monobasic carboxylic acid salt or a MPMD dicarboxylic acid salt. The use according to claim 1 or 2, wherein the organic salt of MPMD is a salt of organic dicarboxylic acid and MPMD, wherein the dicarboxylic acid is selected from oxalic acid, malonic acid, succinic acid, glutaric acid, methyl malonic acid, dimethyl malonic acid, ethyl malonic acid, mesaconic acid, pyruvograd acid, ethyl succinic acid, maleic acid, fumaric acid, itaconic acid, methyl glutaric acid and glutaconic acid. 6. The use according to claim 1 or 2, wherein the organic salt of MPMD is a salt of dicarboxylic acid and MPMD, wherein the dicarboxylic acid is selected from oxalic acid, malonic acid, succinic acid, glutaric acid, methyl malonic acid, dimethyl malonic acid, ethyl malonic acid, pyruvic acid, ethyl succinic acid and methyl glutaric acid. 7. The use according to claim 1 or 2, wherein the organic salt of MPMD is a salt of a dicarboxylic acid and MPMD, wherein the dicarboxylic acid is selected from succinic acid, glutaric acid and methylglutaric acid. The use according to claim 1 or 2, wherein the salt is a mixed salt of diamine (s) and dicarboxylic acid (acids), at least |
| priorityDate | 2012-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 68.